| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910300330703321 |
|
|
Titolo |
The Concise Manual of Apheresis Therapy / / edited by Eisei Noiri, Norio Hanafusa |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Tokyo : , : Springer Japan : , : Imprint : Springer, , 2014 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2014.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (416 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Nephrology |
Internal medicine |
Biomedical engineering |
Internal Medicine |
Biomedical Engineering and Bioengineering |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Part 1. Principles and Technologies -- Chapter 1. Theoretical background of Apheresis Therapy - Norio Hanafusa -- Chapter 2. Methods to Remove Pathogens - Tamami Tanaka -- Chapter 3. Decision to Prescribe PE, DFPP, or PA- Rei Isshiki -- Chapter 4. Plasma Exchange - Daisuke Katagiri -- Chapter 5. Double Filtration Plasmapheresis - Daisuke Katagri -- Chapter 6. Plasma Adsorption- Yasuyuki Watanabe -- Chapter 7. Cryofiltration - Daisuke Katagiri -- Chapter 8. Double Filtration Plasmapheresis Thermo-mode (DF Thermo)- Mizuki Yamano -- Chapter 9. Plasma Diafiltration - Hajime Nakae -- Chapter 10. Direct Plasma Adsorption - Mayumi Miwa -- Chapter 11. Cytapheresis - Yuki Itoh -- Chapter 12. Cell-free and Concentrated Ascites Reinfusion Therapy - Norio Hanafusa -- Part 2. Therapeutic Details -- Chapter 13. Choice of Apheresis Therapy- Eisei Noiri -- Chapter 14. Determination of Dosage and Frequency of Therapy- Norio Hanafusa -- Chapter 15. Vascular Access- Koji Okamoto -- Chapter 16. Anticoagulants - Tetsushi Yamashita -- Part 3. Complications -- Chapter 17. Hypotension - Tsuyoshi Inoue -- Chapter 18. Bleeding Complications and Reduction of Coagulation Factors- Norio Hanafusa -- Chapter 19. Allergies - Motonobu |
|
|
|
|
|
|
|
|
|
|
|
Nakamura -- Chapter 20. Electrolytes Disorders - Motonobu Nakamura -- Chapter 21. Avoiding Complications during Apheresis - Tetsushi Yamashita -- Chapter 22. Infections - Osamu Yamazaki -- Part 4. Autoimmune Disorders -- Chapter 23. Neurological Diseases- Masao Iwagami -- Chapter 24. Dermatological Disorders- Masao Iwagami -- Chapter 25. Kidney Diseases- Masao Iwagami -- Chapter 26. Rheumatoid Arthritis and Collagen Diseases - Hiroko Kanda -- Chapter 27. Blood type incompatible pregnancies - Norio Hanafusa -- Chapter 28. Multiple Myeloma - Tsuyoshi Inoue -- Chapter 29. Dilated Cardiomyopathy - Yoshifumi Hamasaki -- Part 5. Pathogens with Large Molecular Weight.- Chapter 30. Low Density Lipoprotein Apheresis - Kenjiro Honda -- Chapter 31. Endotoxin Adsorption Therapy - Kent Doi -- Part 6. Diseases Necessary to Supply Coagulation Factors -- Chapter 32. Liver Diseases - Kent Doi.- Chapter 33. Thrombotic Thrombocytopenic Purpura and Thrombotic Microangiopathy - Kenjiro Honda.- Chapter 34. Inflammatory Bowel Diseases - Tsuyoshi Inoue.- Chapter 35. Hepatitis C Virus Infection - Shi Lu.- Chapter 36. Drug Intoxications - Motonobu Nakamura -- Chapter 37. Living Related Kidney Transplantation - Hiroo Kawarazaki -- Chapter 38. Peripheral Blood Stem Cell Transplantation- Naoko Watanabe-Okochi -- Part 7. Pediatric Apheresis -- Chapter 39. Apheresis in Children - Motoshi Hattori. |
|
|
|
|
|
|
Sommario/riassunto |
|
This pocket-sized manual serves as a concise and ideal reference work for therapeutic approaches using apheresis. Covering both basic theory and clinical details to facilitate improved treatment and patient outcomes, the text considers a variety of diseases, including myasthenia gravis, multiple sclerosis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, nephrotic syndrome, TTP/TMA, dilated cardiomyopathy, and many other conditions. The book also reviews the growing trend toward adopting this unique therapy for a wide range of health management issues such as morbid obesity and/or type 2 diabetes, and for lowering LDL-cholesterol (cholesterol apheresis) in patients unresponsive to medication or lifestyle modification. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910966754403321 |
|
|
Titolo |
Cyprus : : Fourth Review under the Extended Arrangement under the Extended Fund Facility and Request for Modification of Performance Criteria |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C. : , : International Monetary Fund, , 2014 |
|
|
|
|
|
|
|
ISBN |
|
9781498349444 |
1498349447 |
9781498365086 |
1498365086 |
9781498363037 |
1498363032 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (117 p.) |
|
|
|
|
|
|
Collana |
|
IMF Staff Country Reports |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Economic development - Cyprus |
Fiscal policy - Cyprus |
Structural adjustment (Economic policy) - Cyprus |
Economic indicators - Cyprus |
Banks and Banking |
Macroeconomics |
Money and Monetary Policy |
Public Finance |
Industries: Financial Services |
Banks |
Depository Institutions |
Micro Finance Institutions |
Mortgages |
Debt |
Debt Management |
Sovereign Debt |
Monetary Policy, Central Banking, and the Supply of Money and Credit: General |
Taxation, Subsidies, and Revenue: General |
Fiscal Policy |
Financial Institutions and Services: General |
Banking |
Public finance & taxation |
Finance |
Monetary economics |
|
|
|
|
|
|
|
|
|
|
|
|
Public debt |
Nonperforming loans |
Credit |
Revenue administration |
Financial institutions |
Money |
Loans |
Banks and banking |
Debts, Public |
Revenue |
Cyprus Economic conditions |
Cyprus |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
Cover; CONTENTS; BACKGROUND; RECENT ECONOMIC DEVELOPMENTS; FIGURES; 1. High Frequency Indicators; 2. Employment and Inflation Developments; 3. External Indicators; 4. Recent Fiscal Developments; 5. Financial Sector Developments; MACROECONOMIC OUTLOOK; BOXES; 1. The Household Saving Rate in Cyprus; POLICY DISCUSSIONS; A. Financial Sector Policy: Tackling NPLs and Safeguarding Stability; 2. Challenges in Dealing with NPLs; B. Fiscal Policy: Maintaining Sustainability; C. Fiscal Structural Reforms: Strengthening Institutions; 3. Cyprus's Social Welfare Reform; PROGRAM MODALITIES AND FINANCING |
STAFF APPRAISAL 6. External Debt Sustainability - Bound Tests; 7. Public Debt Sustainability Analysis - Risk Assessment; 8. Public Debt Sustainability Analysis - Realism of Baseline Assumptions; 9. Public Sector Debt Sustainability Analysis - Baseline Scenario; 10. Public Debt Sustainability Analysis - Composition of Public Debt and Alternative Scenarios; 11. Public Debt Sustainability Analysis - Stress Tests; TABLES; 1. Selected Economic Indicators 2008-20; 2. Fiscal Developments and Projections, 2008-20; 3. Calculation of Gross Financing Requirements and Sources of Financing, 2013-17 |
4. Balance of Payments, 2008-205. External Financing Requirements and Sources, 2012-20; 6. Monetary Survey, 2008-20; 7. Indicators of Fund Credit, 2012-20; 8. Schedule of Reviews and Purchases; 9. External Debt Sustainability Framework, 2009-21; 10. Restrictive Measures on Transactions; 11. Selected Reforms-Measures Completed; 12. MEFP Commitments; 13. Conditionality for the Fourth Review; APPENDIX; I. Letter of Intent; ATTACHMENTS; I. Memorandum of Economic and Financial Policies; II. Technical Memorandum of Understanding |
III. Memorandum of Understanding on Specific Economic Policy Conditionality (European Commission) |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This paper focuses on Cyprus’ Fourth Review Under the Extended Arrangement Under the Extended Fund Facility (EFF) and Request for Modification of Performance Criteria. The program remains on track. Fiscal targets for the first quarter were met with considerable margins, |
|
|
|
|
|
|
|
|
|
|
domestic payment restrictions were fully lifted, and the coop sector was consolidated. The authorities intensified efforts to overcome delays in the implementation of structural measures. There are three key policy challenges: (1) addressing the high level of nonperforming loans; (2) maintaining fiscal sustainability; and (3) strengthening institutions to support fiscal consolidation efforts and long-run growth. Risks to the program remain significant, in particular those related to still strong macro-financial linkages. |
|
|
|
|
|
| |